Leuprolide Withdrawn Phase 0 Trials for Polycystic Ovaries Syndrome / BMI >30 kg/m2 / Hyperandrogenemia Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science0
clinicaltrials.gov IdentifierTitleDrugs
NCT01422096Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess